カルナバイオサイエンス(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4572/E00987Carna Biosciences,Inc.
公表日公表担保貸付残高前週比借入残高（自己）前週比借入残高（転貸）前週比
2018/10/26日証協無担保0株0%0株-100%445,403株-0.25%
2018/10/26日証協有担保984,940株-7.37%116,000株-1.02%423,300株-8.3%
2018/10/19日証協無担保0株-100%600株0%446,503株-0.02%
2018/10/19日証協有担保1,063,300株+7.3%117,200株+3.26%461,600株+6.61%
2018/10/12日証協無担保100株0%0株0%446,603株-0.87%
2018/10/12日証協有担保991,000株-7.06%113,500株+1.34%433,000株-6.4%
2018/10/05日証協無担保100株0%0株0%450,503株+2.69%
2018/10/05日証協有担保1,066,267株-4.78%112,000株-2.35%462,600株-4.68%
2018/09/28日証協無担保100株0%0株0%438,694株-9%
2018/09/28日証協有担保1,119,767株+5.94%114,700株+23.87%485,300株+1.55%
2018/09/21日証協無担保100株0%0株0%482,101株+1.26%
2018/09/21日証協有担保1,057,028株+1.01%92,600株+0.98%477,900株+2.62%
2018/09/14日証協無担保100株0%0株0%476,101株+0.02%
2018/09/14日証協有担保1,046,428株-3.04%91,700株-13.98%465,700株-1.88%
2018/09/07日証協無担保0株0%0株0%476,001株-4.74%
2018/09/07日証協有担保1,079,228株-12.47%106,600株-25.35%474,600株-10.87%
2018/08/31日証協無担保0株0%0株0%499,701株+3.54%
2018/08/31日証協有担保1,233,028株-1.33%142,800株-9.79%532,500株+0.26%
2018/08/24日証協無担保0株0%0株0%482,601株+0.54%
2018/08/24日証協有担保1,249,628株-1.65%158,300株-8.97%531,100株-0.77%
2018/08/17日証協無担保0株-100%0株0%480,001株+1.03%
2018/08/17日証協有担保1,270,628株-0.53%173,900株-5.54%535,200株-0.41%
2018/08/10日証協無担保200株+100%0株0%475,101株+0.25%
2018/08/10日証協有担保1,277,428株-4.43%184,100株-8.36%537,400株-4.72%
2018/08/03日証協無担保100株0%0株0%473,902株-0.27%
2018/08/03日証協有担保1,336,628株-4.77%200,900株-9.63%564,000株-3.28%
2018/07/27日証協無担保100株0%0株0%475,202株+0.23%
2018/07/27日証協有担保1,403,556株-3.24%222,300株-0.13%583,100株-3.2%
2018/07/20日証協無担保100株0%0株0%474,110株0%
2018/07/20日証協有担保1,450,556株-3.34%222,600株-0.27%602,400株-3.82%
2018/07/13日証協無担保100株0%0株0%474,110株+0.51%
2018/07/13日証協有担保1,500,656株-2.47%223,200株+0.45%626,300株-3.41%
2018/07/06日証協無担保100株0%0株0%471,710株+2.95%
2018/07/06日証協有担保1,538,656株+2.29%222,200株+1.14%648,400株+1.42%
2018/06/29日証協無担保100株0%0株0%458,193株-1.08%
2018/06/29日証協有担保1,504,156株+7.28%219,700株+0.37%639,300株+9.6%
2018/06/22日証協無担保100株0%0株0%463,202株+0.48%
2018/06/22日証協有担保1,402,056株+6.72%218,900株+4.14%583,300株+3.79%

※株式分割は考慮していませんのでご注意ください。

Page Top